J.J. Lee

521 total citations
11 papers, 57 citations indexed

About

J.J. Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, J.J. Lee has authored 11 papers receiving a total of 57 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 2 papers in Immunology. Recurrent topics in J.J. Lee's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (4 papers). J.J. Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (4 papers). J.J. Lee collaborates with scholars based in United States, Canada and Netherlands. J.J. Lee's co-authors include Boris Sepesi, Stephen G. Swisher, Don L. Gibbons, John V. Heymach, Anne S. Tsao, George R. Blumenschein, William N. William, Faye M. Johnson, Ming Guo and M.S. Kies and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

J.J. Lee

9 papers receiving 56 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.J. Lee United States 4 35 32 12 10 9 11 57
A. Radkowski Poland 5 31 0.9× 22 0.7× 5 0.4× 10 1.0× 7 0.8× 11 70
Magdalena Stankiewicz Poland 4 17 0.5× 15 0.5× 12 1.0× 7 0.7× 6 0.7× 18 60
Philip Camilleri United Kingdom 7 65 1.9× 20 0.6× 17 1.4× 18 1.8× 6 0.7× 11 97
C. Lafond France 4 21 0.6× 45 1.4× 23 1.9× 4 0.4× 12 1.3× 6 63
Leilana Ly United States 4 9 0.3× 54 1.7× 12 1.0× 4 0.4× 12 1.3× 8 61
Alexander S. Martin United States 3 23 0.7× 32 1.0× 29 2.4× 5 0.5× 19 2.1× 4 78
Sarah Derby United Kingdom 4 17 0.5× 19 0.6× 7 0.6× 6 0.6× 4 0.4× 9 45
Mariusz Kwiatkowski United States 4 35 1.0× 39 1.2× 9 0.8× 8 0.8× 14 1.6× 11 55
Luís Carlos Moreira Antunes Brazil 4 20 0.6× 25 0.8× 19 1.6× 5 0.5× 5 0.6× 11 54
Hanneke van der Wijngaart Netherlands 5 19 0.5× 28 0.9× 11 0.9× 7 0.7× 5 0.6× 18 60

Countries citing papers authored by J.J. Lee

Since Specialization
Citations

This map shows the geographic impact of J.J. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Lee more than expected).

Fields of papers citing papers by J.J. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Lee. The network helps show where J.J. Lee may publish in the future.

Co-authorship network of co-authors of J.J. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of J.J. Lee. A scholar is included among the top collaborators of J.J. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J. Lee. J.J. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Zhang, Jianjun, Hai T. Tran, Hong Liu, et al.. (2024). EP.06G.09 Harnessing Real-World Data for Translational Research in Lung Cancer: MD Anderson Thoracic GEMINI Program. Journal of Thoracic Oncology. 19(10). S515–S515. 1 indexed citations
3.
Hong, Lingzhi, Muhammad Aminu, Christian D. Young, et al.. (2024). P2.11A.25 Clinicogenomic Profile of Different Resistance Patterns to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 19(10). S263–S263.
4.
5.
Cascone, Tina, William N. William, Annikka Weissferdt, et al.. (2018). Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC). Annals of Oncology. 29. viii738–viii738. 6 indexed citations
6.
Weissferdt, Annikka, Boris Sepesi, Apar Pataer, et al.. (2018). Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC). Annals of Oncology. 29. viii680–viii680. 4 indexed citations
7.
Gomez, Daniel R., Chad Tang, J. Zhang, et al.. (2018). Local Consolidative Therapy (LCT) Improves Overall Survival (OS) Compared to Maintenance Therapy/Observation in Oligometastatic Non-Small Cell Lung Cancer (NSCLC): Final Results of a Multicenter, Randomized, Controlled Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics. 102(5). 1604–1604. 23 indexed citations
8.
Quek, Kelly, Jiro Fujimoto, C.F. Behrens, et al.. (2017). Intratumor Heterogeneity Is Associated with Survival of Patients with Stage IA Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(8). S1539–S1539. 1 indexed citations
9.
Glisson, Bonnie S., Erminia Massarelli, William N. William, et al.. (2017). Nivolumab and ISA 101 HPV vaccine in incurable HPV-16+ cancer. Annals of Oncology. 28. v403–v404. 17 indexed citations
10.
Reuben, Alexandre, Rachel Gittelman, J. Zhang, et al.. (2017). TCR Repertoire of Lung Cancer: An Association with Tumor Molecular and Clinicopathological Features. Journal of Thoracic Oncology. 12(8). S1539–S1539. 1 indexed citations
11.
Komaki, Ritsuko, Ignacio I. Wistuba, Ximing Tang, et al.. (2012). Vimentin (EMT Marker Protein) Score Predicts Resistance to Erlotinib and Radiation Therapy for Patients With Stage III Non-small Cell Lung Cancer on a Prospective Phase II Trial. International Journal of Radiation Oncology*Biology*Physics. 84(3). S24–S25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Radkowski Breakdown of academic impact, for papers by Magdalena Stankiewicz Breakdown of academic impact, for papers by Philip Camilleri Breakdown of academic impact, for papers by C. Lafond Breakdown of academic impact, for papers by Leilana Ly Breakdown of academic impact, for papers by Alexander S. Martin Breakdown of academic impact, for papers by Sarah Derby Breakdown of academic impact, for papers by Mariusz Kwiatkowski Breakdown of academic impact, for papers by Luís Carlos Moreira Antunes Breakdown of academic impact, for papers by Hanneke van der Wijngaart
Rankless by CCL
2026